Trial
NCT00736450
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI); Genta Incorporated
Condition
Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Intervention
oblimersen sodium
Why stopped
Manufacturer is no longer making the drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-24